Kednapa Thavorn profile picture

Contact Information

Kednapa Thavorn, BPharm, MPharm, PhD
(613)-7378899 ext 72330

Research Administrative Assistant:
Jennifer Brownrigg
Telephone: 613-737-8899
Extension: 73810

ORCID logo

Kednapa Thavorn

Senior Scientist, Clinical Epidemiology Program
Ottawa Hospital Research Institute
Scientific Lead, Health Economics, The Ottawa Methods Centre
Ottawa Hospital Research Institute, The Ottawa Hospital
Associate Professor, School of Epidemiology and Public Health
Faculty of Medicine, University of Ottawa
Adjunct Scientist, Chronic Disease Program
ICES (Institute of Clinical Evaluative Sciences)
Member, Centre for Implementation Research
Ottawa Hospital Research Institute
Visiting Professor, Faculty of Pharmacy
Chiang Mai University, Thailand

Research Interests

  • Health Economics
  • Health Technology Assessment
  • Pharmacoepidemiology
  • Health Services Research
  • Health Equity/Access to care
  • Care for People with Complex Needs
  • Global Health
  • Population Health

More information about the Centre for Implementation Research 

Brief Biography

Dr. Kednapa Thavorn is a Senior Scientist and a Scientific Lead of Health Economics at the Ottawa Hospital Research Institute. She is also an Associate Professor with the School of Epidemiology and Public Health at the University of Ottawa, an Adjunct Scientist at ICES (Full Status), and a Visiting Professor at the Faculty of Pharmacy, Chiang Mai University, Thailand. She holds a Ph.D. in Health Services Research from the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto. She completed post-doctoral fellowship programs in Applied Pharmacoeconomics from the Li Ka Shing Knowledge Institute, St. Michael’s Hospital and Health Services Research from the IHPME, University of Toronto.

Her research focuses on health economics, health technology assessment, pharmacoepidemiology, health equity, care for people with complex needs, and population health. As a health economist, she has collaborated with patient partners, clinicians, researchers, and policymakers in Canada and other countries on various health services research and health technology assessment projects.

Selected Publications

Papers in refereed journals: (N=247)

  1. Mahmoud HA*, Thavorn K, Mulpuru S, McIsaac D, Abdelrazek MA, Mahmoud AA, Forster AJ. Barriers and facilitators to improving patient safety learning systems: a systematic review of qualitative studies and meta-synthesis. BMJ Open Qual 2023 ;12(2):e002134. doi: 10.1136/bmjoq-2022-002134

  2. Mital S, Kelly D, Hughes C, Nosyk B, Thavorn K, Nguyen HV. Estimated cost-effectiveness of point-of-care testing in community pharmacies versus self-testing and standard laboratory testing for HIV. AIDS. 2023 Feb 17. doi: 10.1097/QAD.0000000000003526.

  3. Khan F*, Thavorn K, Coyle D, van Katwyk S, Tritschler T, Hutton B, Le Gal G, Rodger MA, Fergusson DA. Protocol for a Modelling Study to Assess the Clinical and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. BMJ Open. 2023;13(1):e053927. doi: 10.1136/bmjopen-2021-053927

  4. Kekre N, Hay KA, Webb JR, Mallick R, Balasundaram M, Sigrist MK, Clement AM, Nielsen JS, Quizi J, Yung E, Brown SD, Dreolini L, Waller DD, Smazynski J, Gierc NS, Loveless BC, Clark K, Dyer T, Hogg R, McCormick L, Gignac M, Bell S, Chapman DM, Bond D, Yong S, Fung R, Lockyer HM, Hodgson V, Murphy C, Subramanian A, Wiebe E, Yoganathan P, Medynski L, Vaillan DC, Black A, McDiarmid S, Kennah M, Hamelin L, Song K, Narayanan S, Rodrigo JA, Dupont S, Hawrysh T, Presseau J, Thavorn K, Lalu MM, Fergusson DA, Bell JC, Atkins H, Nelson BH, Holt RA. CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies. Front Immunol. 2022;13:1074740. doi: 10.3389/fimmu.2022.1074740

  5. Singh S, Tahsin F, Nie JX, McKinstry B, Thavorn K, Upshur R, Harvey S, Wodchis W, Gray CS. Exploring the perspectives of primary care providers on use of the electronic Patient Reported Outcomes tool to support goal-oriented care: A qualitative study. BMC Medical Informatics and Decision Making. 2021;21, 366. doi: 10.1186/s12911-021-01734-0

  6. Nochaiwong S, Ruengorn C, Awiphan R, Chai-Adisaksopha C, Sood MM, Hutton B, Thavorn K. Use of Serotonin Reuptake Inhibitor Antidepressants Concomitant with Antithrombotic Therapy and the Risk of Bleeding Complications: A Systematic Review and Meta-Analysis. Annals of Medicine. 2021;54(1):80-97. doi:  10.1080/07853890.2021.2017474 

Diseases, conditions and populations of interest

Research and clinical approaches